(1 - 14 von 25
)
Health Care 50 | Time.com
time.com
Dr. Sean Harper. Ending Migraine Pain. In May, Aimovig, a drug Harper developed at biotech company Amgen, became the first migraine-prevention drug to ...
Amgen Revises Guidance
www.finanznachrichten.de
Sean Harper, executive vice president of Research and Development, has decided to retire and plans to pursue opportunities in the early-stage biotechnology community. …
Amgen's R&D chief Sean Harper retires to seek biotech post - PMLiVEwww.pmlive.com › pharma_news › amgens_r_and_...
www.pmlive.com
· Amgen's long-serving head of R&D Sean Harper (pictured) is retiring from his position and is looking for “opportunities in the early-stage ...
Amgen To Terminate Participation In Co-development Of Brodalumad
www.finanznachrichten.de
'During our preparation process for regulatory submissions, we came to believe that labeling requirements likely would limit the appropriate patient population for brodalumab,' said Sean Harper …
sortiert nach Relevanz / Datum